Antares Pharma: What The Market Is Missing
As the chart below illustrates, Antares Pharma (ATRS) stock has been down and under pressure since the FDA approval of Clarus Therapeutics' TRT drug …
Peak Bggr flipped this story into Biotech Investing•1742d